These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20166497)

  • 1. Imaging findings of a cutaneous B-cell lymphoma.
    Vanhoenacker FM; Baten A; Vandeputte V
    JBR-BTR; 2009; 92(6):285-8. PubMed ID: 20166497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R; Xiu Y; Zhuang HM; Alavi A
    Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
    Qiu L; Tu G; Li J; Chen Y
    Nucl Med Commun; 2017 Feb; 38(2):106-116. PubMed ID: 27792043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging by ¹⁸F-FDG PET/CT of diffuse large B-cell lymphoma with cellulitis.
    Zhang Y; Li B; Cai L; Shi H; Hou J
    Hell J Nucl Med; 2015; 18(3):271-2. PubMed ID: 26574700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
    Feuerman H; Snast I; Amitay-Laish I; Bairey O; Barzilai A; Feinmesser M; Mimouni D; Even-Sapir E; Hodak E
    Isr Med Assoc J; 2019 Sep; 21(9):580-584. PubMed ID: 31542900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 FDG positron emission tomography findings in primary pancreatic lymphoma.
    Yoon SN; Lee MH; Yoon JK
    Clin Nucl Med; 2004 Sep; 29(9):574-5. PubMed ID: 15311130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
    Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.
    Shapiro M; Yun M; Junkins-Hopkins JM; Vittorio CC; Schulman N; Saidman BH; Fried RG; Rook AH; Alavi A
    J Am Acad Dermatol; 2002 Oct; 47(4):623-8. PubMed ID: 12271315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
    von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
    Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type.
    Samarghandi A; Gru AA; Natwa M; Barker DW
    Clin Nucl Med; 2015 Jun; 40(6):506-8. PubMed ID: 25742229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
    Kumar R; Xiu Y; Dhurairaj T; Yu JQ; Alavi A; Zhuang H
    Clin Nucl Med; 2005 Apr; 30(4):246-8. PubMed ID: 15764881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous lymphomas].
    Ingen-Housz-Oro S; Bagot M
    Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
    Masada T; Matsumoto Y; Kawai N; Tamiya T; Nagao S
    No Shinkei Geka; 2004 Aug; 32(8):859-64. PubMed ID: 15478653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
    Vasanawala MS; Wang Y; Quon A; Gambhir SS
    Clin Nucl Med; 2006 Sep; 31(9):534-7. PubMed ID: 16921276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.
    Berk V; Yildiz R; Akdemir UO; Akyurek N; Karabacak NI; Coskun U; Benekli M
    Clin Nucl Med; 2008 May; 33(5):365-6. PubMed ID: 18431160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prechemotherapy positron emission tomography-CT imaging, acquired in the treatment position, to help plan involved nodal radiotherapy for a patient with diffuse large B-cell lymphoma.
    David SP; Rees HS; MacManus MP
    J Med Imaging Radiat Oncol; 2011 Apr; 55(2):236-41. PubMed ID: 21501416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.